Groowe Groowe / Newsroom / ABBV
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ABBV News

ABBVIE INC.

AbbVie IBD Scholarship Program Marks 15 Years: Applications Open for 2026

globenewswire.com
ABBV

Glioblastoma Multiforme Market Intelligence Report 2026-2030 & 2035: Advanced Targeted Drugs Propel Industry Growth

globenewswire.com
PFE ABBV BMY AZN MRK

Gliosarcoma Market Intelligence Report 2026-2030 & 2035: Expansion of Molecular Testing and Increased Research Funding is Driving Industry Growth

globenewswire.com
NVCR MRK PFE ABBV

Mission BioCapital Announces Opening of $4 Million 2026 Platinum Program Contest and 2025 Platinum Ticket Investments

prnewswire.com
ABBV LLY

Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 & 2035 - United Therapeutics Corporation, APEIRON Biologics, Pfizer, Bayer, and Amgen Dominate

globenewswire.com
UTHR PFE AMGN JNJ ABBV MRK BMY MAC

FORE Biotherapeutics Receives Breakthrough Therapy Designation for Plixorafenib

businesswire.com
ABBV MRK

DIA's LIFT Series Brings Startup Pitch Competitions, Innovation Programming to Global Annual Meeting

prnewswire.com
LLY ABBV MRNA

Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight

globenewswire.com
BIIB NVS VTRS UCB BMY ABBV AZN CABA AUR GSK VERA KYMR NKTR VRTX ARWR

ADC Contract Manufacturing Market Report 2026 (7th Edition) | Commercial Scale Dominates ADC Manufacturing with 90% Market Share | A Clear Analysis of Market Trends, Drivers, Challenges, and Opportunities

globenewswire.com
ABBV

PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment

globenewswire.com
NVO LLY PFE ABBV